2022 Annual Meeting

18th Annual Meeting of the
Oligonucleotide Therapeutics Society

October 2-5, 2022

Hilton Phoenix Resort at the Peak,
Phoenix, Arizona, USA

More information to follow as it becomes available.

Registration and abstracts will open by early May
July 19 – Awards Application Deadline
July 19 – Short Talk Abstract Deadline
August 19 – Poster Abstract Deadline
September 9 – Invited Speaker Abstract Deadline

Co-Chairs:

Annemieke Aartsma-Rus, PhD
Leiden University Medical Center

Keith T. Gagnon, PhD
Southern Illinois University

Organizing Committee Members:

Frank Bennett, PhD
Ionis Pharmaceuticals

David Corey, PhD
UT Southwestern

Masad J. Damha, PhD
McGill University

Maja Janas De Angelis, PhD, DABT
Alnylam Pharmaceuticals

Hassan Fakih, PhD
RNA Therapeutics Institute,
UMass Chan Medical School

Chantal Ferguson, MD/PhD Candidate
RNA Therapeutics Institute,
UMass Chan Medical School

Martin Maier, PhD
Alnylam Pharmaceuticals

Melissa J. Moore, PhD
Moderna

Arthur M. Krieg, MD
Checkmate Pharmaceuticals

Aurélie Goyenvalle, PhD, DR Inserm
UMR 1179 INSERM-UVSQ

Laura Sepp-Lorenzino, PhD
Intellia Therapeutics

Marie Wikström Lindholm, PhD
Silence Therapeutics

John Whittaker, PhD
University of Cambridge